| Sign In to gain access to subscriptions and/or personal tools. |
The U.S. Food and Drug Administration's Evaluation of the Safety of Animal ClonesA Failure to Recognize the Normativity of Risk Assessment ProjectsUniversity of Rhode Island
Weill Cornell Medical College The U.S. Food and Drug Administration (FDA) announced recently that food products derived from some animal clones and their offspring are safe for human consumption. In response to criticism that it had failed to engage with ethical, social, and economic concerns raised by livestock cloning, the FDA argued that addressing normative issues prior to issuing a final ruling on animal cloning is not part of its mission. In this article, the authors reject the FDA's claim that its mission to protect and advance public health can be accomplished without considering ethical issues or without making value judgments. The authors offer two arguments in support of their position. First, the agency's mission statement presupposes significant normative commitments and judgments. Second, the FDA's risk assessment of food products from cloned animals and their offspring is itself clearly shaped by a variety of normative commitments.
Key Words: Food and Drug Administration • risk assessment • food safety • animal cloning • value judgments
Bulletin of Science, Technology & Society, Vol. 29, No. 1,
9-17 (2009) |
|||
 |
|
|
 |
|
Sign In to gain access to subscriptions and/or personal tools.
